
R1 RCM Inc. – NASDAQ:RCM
R1 RCM stock price monthly change
R1 RCM stock price quarterly change
R1 RCM stock price yearly change
R1 RCM key metrics
Market Cap | 6.04B |
Enterprise value | 5.82B |
P/E | -94.87 |
EV/Sales | 2.65 |
EV/EBITDA | 34.59 |
Price/Sales | 1.83 |
Price/Book | 1.48 |
PEG ratio | -1.07 |
EPS | -0.07 |
Revenue | 2.31B |
EBITDA | 459.1M |
Income | -32.1M |
Revenue Q/Q | 10.68% |
Revenue Y/Y | 17.60% |
Profit margin | -3.55% |
Oper. margin | 2.45% |
Gross margin | -62.02% |
EBIT margin | 2.45% |
EBITDA margin | 19.85% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeR1 RCM stock price history
R1 RCM stock forecast
R1 RCM financial statements
Jun 2023 | 560.7M | 300K | 0.05% |
---|---|---|---|
Sep 2023 | 572.8M | 1.3M | 0.23% |
Dec 2023 | 575.1M | 1.4M | 0.24% |
Mar 2024 | 603.9M | -35.1M | -5.81% |
Sep 2025 | 764.09M | 48.42M | 6.34% |
---|---|---|---|
Oct 2025 | 744.03M | 27.98M | 3.76% |
Dec 2025 | 779.72M | 36.98M | 4.74% |
Mar 2026 | 791.75M | 29.74M | 3.76% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 5074200000 | 2.33B | 45.94% |
---|---|---|---|
Sep 2023 | 5057000000 | 2.29B | 45.39% |
Dec 2023 | 4960200000 | 2.20B | 44.53% |
Mar 2024 | 5795200000 | 2.97B | 51.28% |
Jun 2023 | 57.4M | -21.6M | -16.7M |
---|---|---|---|
Sep 2023 | 109.2M | -28.4M | -38.4M |
Dec 2023 | 118.8M | -27.2M | -83.4M |
Mar 2024 | 46.7M | -698.4M | 656.1M |
R1 RCM alternative data
Aug 2023 | 27,200 |
---|---|
Sep 2023 | 27,200 |
Oct 2023 | 27,200 |
Nov 2023 | 27,200 |
Dec 2023 | 27,200 |
Jan 2024 | 27,200 |
Feb 2024 | 27,200 |
Mar 2024 | 29,400 |
Apr 2024 | 29,400 |
May 2024 | 29,400 |
Jun 2024 | 29,400 |
Jul 2024 | 29,400 |
R1 RCM other data
Period | Buy | Sel |
---|---|---|
Nov 2024 | 0 | 30548388 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | TCP-ASC ACHI SERIES LLLP director, 10 percent owner: | Common Stock | 30,548,388 | $14.28 | $436,292,077 | ||
Option | HENNEMAN JOHN B III director | Director Stock Option (right to buy) | 50,000 | $2.61 | $130,500 | ||
Option | HENNEMAN JOHN B III director | Common Stock | 50,000 | $2.61 | $130,500 | ||
Sale | HENNEMAN JOHN B III director | Common Stock | 50,000 | $17.17 | $858,650 | ||
Sale | EVANS RICHARD B. JR. officer: Principa.. | Common Stock | 17,000 | $16.84 | $286,229 | ||
Sale | EVANS RICHARD B. JR. officer: Principa.. | Common Stock | 12,000 | $16.69 | $200,280 | ||
Sale | SPARBY JOHN M. officer: President | Common Stock | 20,000 | $16.36 | $327,280 | ||
Purchase | RIVAS LEE director, officer: Chief Execut.. | Common Stock | 71,767 | $13.93 | $1,000,001 | ||
Sale | TCP-ASC ACHI SERIES LLLP director, 10 percent owner | Common Stock | 15,000,000 | $20.43 | $306,375,000 | ||
Sale | SPARBY JOHN M. officer: Executive Vice Preside.. | Common Stock | 40,000 | $25.01 | $1,000,280 |
Quarter | Transcript |
---|---|
Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 27 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 4 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 2 Aug 2023 | Q2 2023 Earnings Call Transcript |
R1 RCM (RCM) Presents at the 43rd Annual Cowen Healthcare Conference - Slideshow
R1 RCM: Cloudmed Already Paying Dividends, Look For Double-Digit Growth In FY23
R1 RCM: Reversal Rally Well Supported In The Data
R1 RCM: Long-Term Growth Story Intact Following Cloudmed Acquisition
R1 RCM (RCM) Presents at 2022 RBC Capital Markets Healthcare Conference
R1 RCM Inc. 2022 Q1 - Results - Earnings Call Presentation
R1 RCM: Undervalued Stock With 62.5% Upside
R1 RCM (RCM) Presents At 42nd Annual Cowen Health Care Conference
R1 RCM (RCM) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference
-
When is R1 RCM's next earnings date?
Unfortunately, R1 RCM's (RCM) next earnings date is currently unknown.
-
Does R1 RCM pay dividends?
No, R1 RCM does not pay dividends.
-
How much money does R1 RCM make?
R1 RCM has a market capitalization of 6.04B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24.79% to 2.25B US dollars.
-
What is R1 RCM's stock symbol?
R1 RCM Inc. is traded on the NASDAQ under the ticker symbol "RCM".
-
What is R1 RCM's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of R1 RCM?
Shares of R1 RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are R1 RCM's key executives?
R1 RCM's management team includes the following people:
- Mr. Joseph Gerard Flanagan Pres, Chief Executive Officer & Director(age: 54, pay: $1,050,000)
- Mr. Gary S. Long Executive Vice President & Chief Commercial Officer(age: 54, pay: $692,740)
- Mr. Richard B. Evans Jr. Senior Vice President, Corporation Controller & Chief Accounting Officer(age: 57, pay: $393,270)
- Ms. Rachel Wilson Executive Vice President, Chief Financial Officer & Treasurer(age: 52, pay: $349,680)
-
How many employees does R1 RCM have?
As Jul 2024, R1 RCM employs 29,400 workers.
-
When R1 RCM went public?
R1 RCM Inc. is publicly traded company for more then 8 years since IPO on 16 Mar 2017.
-
What is R1 RCM's official website?
The official website for R1 RCM is r1rcm.com.
-
Where are R1 RCM's headquarters?
R1 RCM is headquartered at 434 W. Ascension Way, Murray, UT.
-
How can i contact R1 RCM?
R1 RCM's mailing address is 434 W. Ascension Way, Murray, UT and company can be reached via phone at +31 23247820.
R1 RCM company profile:

R1 RCM Inc.
r1rcm.comNASDAQ
29,400
Medical - Healthcare Information Services
Healthcare
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.
Murray, UT 84123
CIK: 0001910851
ISIN: US77634L1052
CUSIP: 77634L105